Uncategorized


September 25, 2025

Rx Pricing: MFN Demo Incoming?

By John Leppard

The White House’s Office of Management & Budget’s (OMB) disclosure this morning that it is reviewing what appears to be a Most Favored Nation (MFN) drug pricing model is consistent with our long-held expectations, if…

Read More >>

September 22, 2025

DC Quick Takes: Govt. Shutdown, NDAA, Durbin 2.0 (V, MA), Interest on Fed Reserves (JPM, C, BAC, WFC), and GAIN AI Act (NVDA, AMD)

By Joe Lieber

We continue to believe that the odds of a government shutdown are at least 75%, though that might be too low given that Congress is out of session this week. The Senate is scheduled back…

Read More >>

September 18, 2025

Odds and Impacts of a Government Shutdown

By Joe Lieber

We are bumping our odds to ~75% (up from 65%) that a government shutdown occurs on Oct. 1. This is partially in light of the Democrats’ funding proposal, which includes:   A continuing resolution (CR) funding…

Read More >>

September 15, 2025

Capitol Policy Weekly: Government Shutdown/Funding, NDAA, Healthcare, and the HIRE Act

By Joe Lieber

Both chambers of Congress are in session this week before a scheduled recess next week for Rosh Hashana, though we suspect that break will be cut short given the need to avoid a government shutdown…

Read More >>

September 11, 2025

[EXAS, GH] Colorectal Cancer Coverage to Get More Crowded

By John Leppard

With CMS reopening its coverage policy for colorectal cancer (CRC) screening yesterday after the close, it seems likely that the space will get a bit more crowded for EXAS and GH, as we would expect…

Read More >>

September 10, 2025

Status of Medicaid Work Requirements Among States [CNC, MOH, CYH, HCA, THC, UHS, ACHC, MMS]

By Beth Steindecker

Headline risk to Medicaid insurers [CNC, MOH], hospitals [CYH, HCA, THC], behavioral providers [UHS, ACHC], and Medicaid contractors [MMS] is likely to ramp up in the coming months as 15 states take affirmative steps toward…

Read More >>

September 10, 2025

Trade Potpourri: IEEPA, GOOG and the EU, China and India and the GAIN AI Act (NVDA, AMD)

By Joe Lieber

Below our are thoughts on the following recent trade issue developments: The U.S. Supreme Court decision to hear the Trump administration’s appeal of a lower court ruling invalidating the president’s reciprocal and fentanyl tariffs under…

Read More >>

September 10, 2025

Rx Advertising: Policy Quick Take

By John Leppard

While we can at this point give no better than tossup odds to FDA plans to curtail direct-to-consumer (DTC) drug advertisements surviving inevitable legal challenges, we caution that the enforcement approach outlined by the agency…

Read More >>

September 9, 2025

[Hospitals, Nursing Homes, Medicaid Providers] CMS Guidance on SDPs Fleshing Out OBBB; Possible Negative Bias?

By Beth Steindecker

Late Tuesday, CMS released a letter to state Medicaid offices with its preliminary interpretations of the One Big Beautiful Bill (OBBB) Act’s provision placing total payment limits on hospitals, nursing homes, and certain practitioners at…

Read More >>

September 8, 2025

Capitol Policy Weekly: Government Funding, the Fed and Crypto

By Joe Lieber

With both chambers of Congress in session this week, talks are expected to pick up over funding the government beyond the end of the current fiscal year.  We could also see Fed nominee Stephen Miran…

Read More >>